Advertisement

Bindegewebetumoren der Haut

  • H. Audring
  • W. Sterry

Zusammenfassung

Bindegewebetumoren der Haut entstehen aus den Zellen des dermalen, periadnexalen, perivaskulären, subkutanen und faszialen Bindegewebes. Sie sind überwiegend in der Dermis lokalisiert und können das subkutane Fettgewebe involvieren. Die Beteiligung von tiefer gelegenen Strukturen, beispielsweise der Faszie, kommt in Ausnahmefällen vor. Dermal gelegene Tumoren sind prognostisch günstiger als subkutane Pendants.

Synonym

Elastfibroma dorsi Histiozytom Fibroma durum sklerosierendes Hämangiom subepidermale noduläre Fibrose „low-grade myofibroblastic sarcoma“ Fasciitis nodularis pseudosarcomatosa „nodular fasciitis“ kutane fokale Muzinose — die kutane myxoide Zyste auch digitale muköse Zyste werden teilweise als Entität abgegrenzt 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Caux C, Vanbervliet B, Massacrier C et al. (1996) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 184: 695–706PubMedCrossRefGoogle Scholar
  2. Fletcher CDM (1998) Myofibroblastic tumors: An Update. Verh Dtsch Ges Pathol 82: 75–82PubMedGoogle Scholar
  3. Gabbiani G (1996) The cellular derivation and the life span of the myofibroblast. Path Res Pract 192: 708–711PubMedCrossRefGoogle Scholar
  4. Mentzel T, Katenkamp D (1998) Myofibroblastäre Tumoren. Pathologe 19: 176–186PubMedCrossRefGoogle Scholar
  5. Weiss SW, Nickoloff BJ (1993) CD34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 17: 10391045Google Scholar
  6. Cramer HJ, Kahlert G (1968) Über Bindegewebsnaevi. Hautarzt 19: 251–256PubMedGoogle Scholar
  7. Schorr WF, Opitz JM, Reyes CN (1972) The connective tissue nevus-ostiopoikilosis syndrome. Arch Dermatol 106: 208–214PubMedCrossRefGoogle Scholar
  8. Uitto J, Santa-Cruz DJ, Eisen AZ (1980) Connective tissue nevi of the skin. J Am Acad Dermatol 3: 441–461PubMedCrossRefGoogle Scholar
  9. Enzinger FM, Weiss S (eds) (1994) Benign fibrous tissue tumors. In: Soft tissue tumors, 3rd edn. Mosby, St. Louis, pp 187–191Google Scholar
  10. Kahn HJ, Hanna WM (1995) „Aberrant elastic“ in elastofibroma: An immunohistological and ultrastructural study. Ultrastruct Pathol 19: 45–50Google Scholar
  11. Ruelas-Villavicencio AL, Aponte-Paredes PS, Ortiz-Hidalgo C (1999) CD34 expression in elastofibroma: Clinicopathological, histochemical, and immunohistochemical study in four cases. Abstract Rev Invest Clin 51: 11–16Google Scholar
  12. Schepel JA, Wille J, Seldenrijk CA, van Ramshorst B (1998) Elastofibroma: A familial occurrence. Eur J Surg 164: 557–558Google Scholar
  13. Nemeth AJ, Penneys NS (1989) Factor XIIIa is expressed by fibroblasts in fibrovascular tumors. J Cutan Pathol 16: 266–271PubMedCrossRefGoogle Scholar
  14. Pack S, Turner ML, Zhuang Z et al. (1998) Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene. J Invest Dermatol no: 438 440Google Scholar
  15. Roach ES, Gomez MR Northrup H (1998) Tuberous Sclerosis Complex Consensus Conference: Revised clinical diagnostic criteria. J Child Neurol 13: 624–628Google Scholar
  16. Yamamoto T, Katajama I, Nishioka K (1996) Fibropapule multiplex of the nose: A variant of Cowden’s disease? Dermatology 192: 379–381PubMedCrossRefGoogle Scholar
  17. Cerio R, Rao BK, Spaull J, Wilson Jones E (1989) An immunohistochemical study of fibrous papule of the nose. J Cutan Pathol 16: 194–198PubMedCrossRefGoogle Scholar
  18. Tope WD, Sangueza OP (1994) Rhinophymas fibrous variant. Histopathology and immunohistochemistry. Am J Dermatop atho l 16: 307–310Google Scholar
  19. Ferenczy A, Richart RM, Wrigt TC (1991) Pearly penile papules: Absence of human papilloma virus DNA by polymerase chain reaction. Obstet Gynecol 78: 118–122Google Scholar
  20. O’Neil CA, Hansen RC (1995) Pearly penile papules on the shaft–letter. Arch Dermatol 131: 491–492PubMedCrossRefGoogle Scholar
  21. Perrin C, Baran R (1994) Invaginated fibrokeratoma with matrix differentiation: A new histological variant of acquired fibrokeratoma. Br J Dermatol 130: 654–657Google Scholar
  22. Spitalny AD, Lavery LA (1992) Acquired fibrokeratoma of the heel. J Foot Surg 31: 509–511PubMedGoogle Scholar
  23. Cribier B, Gambini C, RaineroM, Grosshans E (1995) Multi-nucleate cell angiohistiocytoma. A review and report of four cases. Acta Dermatol Venereol 75: 337–339Google Scholar
  24. Smolle J, Auboeck L, Gogg-Retzer I, Soyer HP, Kerl H (1989) Multinucleate cell angiohistiocytoma: A clinicopathological, immunohistochemical and ultrastructural study. Br J Dermatol 121: 113–121Google Scholar
  25. Banik R, Lubach D (1987) Skin tags: Localization and frequencies according to sex and age. Dermatologica 174: 180–183Google Scholar
  26. Eads TJ, Chuang TY, Fabre VC, Farmer ER, Hood AF (1996) The utility of submitting fibroepithelial polyps for histological examination. Arch Dermatol 132: 1459–1462PubMedCrossRefGoogle Scholar
  27. Morgan MB, Howard HG, Everett MA (1997) Epithelial induction in dermatofibroma: A role for the epidermal growth factor ( EGF) receptor. Am J Dermatopathol 19: 35–40Google Scholar
  28. Nestle FO, Nickoloff VI, Burg G (1995) Dermatofibroma: An abortive immunoreactive process mediated by dermal dendritic cells? Dermatology 190: 265–268PubMedCrossRefGoogle Scholar
  29. Glusac EJ, Barr RJ, Everett MA, Pitha J, Santa Cruz DJ (1994)Google Scholar
  30. Epithelioid cell histiocytoma. Am J Surg Pathol 18: 583–590 Junkins-Hopkins JM, Johnson WC (1998) DesmoplasticGoogle Scholar
  31. fibroblastoma. J Cutan Pathol 25: 450–454Google Scholar
  32. Zelger BG, Zelger B (1998) Dermatofibrome. Ein klinisch-pathologisches Klassifikationsschema. Pathologe 19: 412–419Google Scholar
  33. Zelger BW, Steiner H, Kutzner H (1996) Clear cell dermatofibroma. Am J Surg Pathol 20: 483–491PubMedCrossRefGoogle Scholar
  34. Zelger BG, Zelger B (1998) Dermatofibrome. Ein klinisch-pathologisches Klassifikationsschema. Pathologe 19: 412–419Google Scholar
  35. Calonje E, Fletcher CDM (1993) New entities in soft tissue tumors. Pathologica 85: 1–15PubMedGoogle Scholar
  36. Calonje E, Mentzel T, Fletcher CDM (1994) Cellular benign fibrous histiocytoma. Am J Surg Pathol 18: 668–676PubMedCrossRefGoogle Scholar
  37. Sass U, André J, Noel CH et al. (1994) Tumeur plexiforme fibrohistiocytaire. Ann Dermatol Venereol 121: 109–112PubMedGoogle Scholar
  38. Fletcher CDM (1998) Myofibroblastic tumors: An Update. Verh Dtsch Ges Pathol 82: 75–82PubMedGoogle Scholar
  39. Kamino H, Reddy VB, Gero M, Greco MA (1992) Dermatomyofibroma. A benign cutaneous, plaque-like proliferation of fibroblasts and myofibroblasts in young adults. J Cutan Pathol 19: 85–93Google Scholar
  40. Kutzner H (1998) Perivaskuläre Myome: ein neues Konzept „myofibroblastärer“ Tumoren mit perivaskulärer myoider Differenzierung. Verh Dtsch Ges Pathol 82: 301–308PubMedGoogle Scholar
  41. Kutzner H, Hügel H, Rütten A, Braun M (1993) Erworbenes gutartiges Myofibrom der Haut ( Adultes Myofibrom ). Hautarzt 44: 561–568Google Scholar
  42. Mentzel T, Katenkamp D (1998) Myofibroblastäre Tumoren. Pathologe 19: 176–186PubMedCrossRefGoogle Scholar
  43. Mentzel T, Calonje E, Fletcher CDM (1993) Dermatomyofibroma: Additional observations on a distinctive cutaneous myofibroblastic tumor with emphasis on differential diagnosis. Br J Dermatol 129: 69–73Google Scholar
  44. Dal Cin P, Sciot R, De Smet L, van den Berge H (1998) Translocation 2;11 in a fibroma of tendon sheath. Histopathology 32: 433–435CrossRefGoogle Scholar
  45. Eckert F, Schauch B (1992) Das Sehnenscheidenfibrom. Ein Fallbericht mit immunhistochemischen Untersuchungen. Hautarzt 43: 92–96Google Scholar
  46. Maluf HM, DeYong BR, Swanson PE, Wick MR (1995) Fibroma and giant cell tumor of the tendon sheath: A comparative histological and immunohistological study. Mod Pathol 8: 155–159Google Scholar
  47. Sciot R, Samson I, van den Berge H, van Damme B, Dal-Cin P (1999) Collagenous fibroma (desmoplastic fibroma): Genetic link with fibroma of tendon sheath? Mod Pathol 12: 565–568PubMedGoogle Scholar
  48. Goldblum JR, Tuthill RJ (1997) CD34 and factor XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma. Am J Dermatopathol 19: 147–153PubMedCrossRefGoogle Scholar
  49. Kosanke U (1999) Ergebnisse der Therapie des Dermatofibrosarcoma protuberans mit Hilfe der mikrographisch kontrollierten Chirurgie. Medizinische Dissertation, Klinik für Dermatologie/Charité, Humboldt-Universität zu BerlinGoogle Scholar
  50. Kutzner H (1993) Expression of human progenitor cell antigen CD34 (HPCA-i) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalinfixed, paraffin-embedded tissue. Am J Acad Dermatol 28: 613–617CrossRefGoogle Scholar
  51. Zelger B, Sidoroff A, Stanzi U et al. (1994) Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. Am J Surg Pathol 18: 677–686PubMedCrossRefGoogle Scholar
  52. Ding J, Hashimoto H, Sugimoto T, Tsuneyoshi M, Enjoji M (1990) Bednar tumor (pigmented dermatofibrosarcoma protuberans). Acta Pathol Jpn 40: 744–754PubMedGoogle Scholar
  53. Goodland JR, Mentzel T, Fletcher CDM (1995) Low grade fibromyxoid sarcoma: A clinicpathological analysis of eleven new cases in support of a distinct entity. Histopathology 26: 229–237Google Scholar
  54. Orlandi A, Bianchi L, Spagnoli LG (1998) Myxoid dermatofibrosarcoma protuberans: Morphological, ultrastructural and immunohistochemical features. J Cutan Pathol 25: 386–393Google Scholar
  55. Calonje E, Fletcher CDM (1996) Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: Clinicopathologic analysis in 5 cases. J Cutan Pathol 23: 30–36PubMedCrossRefGoogle Scholar
  56. Sanz-Trelles A, Ayala-Carbonero A, Rodrigo-Fernandez I, Weil-Lara B (1998) Leiomyomatous nodules and bundles of vascular origin in the fibrosarcomatous variant of dermatofibrosarcoma protuberans. J Cutan Pathol 25: 44–49PubMedCrossRefGoogle Scholar
  57. Fletcher CDM (1998) Recent developments in soft tissue tumors. Verh Dtsch Ges Pathol 82: 33–46PubMedGoogle Scholar
  58. Silverman JS, Tamsen A (1998) A cutaneous case of giant cell angiofibroma occurring with dermatofibrosarcoma protuberans and showing bimodal CD34+ fibroblastic and FXIIIa+ histiocytic immunophenotype. J Cut Pathol 26: 265–270CrossRefGoogle Scholar
  59. Mentzel T, Katenkamp D, Fletcher CDM (1996) Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course. Pathologe 17: 116–121Google Scholar
  60. de Saint-Aubain-Somerhausen N, Rubin BP, Fletcher CD (1999) Myxoid solitary fibrous tumor: A study of seven cases with emphasis on differential diagnosis. Mod Pathol 12: 463–471Google Scholar
  61. Eyden BP, Christensen L, Tagore V, Harris M (1992) Myofibrosarcoma of subcutaneous soft tissue of the cheek. J Submicrosc Cytol 24: 307–313Google Scholar
  62. Mentzel T, Dry S, Katenkamp D, Fletcher CDM (1998) Low-grade myofibroblastic sarcoma. Am J Surg Pathol 22: 1228–1238PubMedCrossRefGoogle Scholar
  63. Fish FS (1996) Soft tissue sarcomas in dermatology. Dermatol Surg 22: 268–273PubMedGoogle Scholar
  64. Hollowood K, Fletcher CDM (1995) Malignant fibrous histiocytoma: Morphologic pattern or pathologic entity? Semin Diagn Pathol 12: 210–220PubMedGoogle Scholar
  65. Lazova R, Moynes R, May D, Scott G (1997) LN-2 (CD74) a marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer 79: 2115–2124PubMedCrossRefGoogle Scholar
  66. Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, Fletcher CDM (1996) Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 20: 391–405PubMedCrossRefGoogle Scholar
  67. Ehrlich HP, Desmoulière A, Diegelmann RF et al. (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145: 105–113PubMedGoogle Scholar
  68. Lee TY, Chin GS, Kim WJ; Chau D, Gittes GK, Longaker MT (1999) Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 43: 179 - i84PubMedGoogle Scholar
  69. Goodlad JR, Fletcher CDM (1990) Intradermal variant of nodular „fasciitis“. Histopathology 17: 569–571PubMedCrossRefGoogle Scholar
  70. Kiryu H, Takeshita H, Hori Y (1997) Proliferative Fasciitis. Am J Dermatopathol 19: 396–399PubMedCrossRefGoogle Scholar
  71. Lai FM-M, Lam WY (1993) Nodular fasciitis of the dermis. J Cutan Pathol 20: 66–69PubMedCrossRefGoogle Scholar
  72. Price SK, Kahn LB, Saxe N (1993) Dermal and intravascular fasciitis. Am J Dermatopathol 15: 539–543PubMedCrossRefGoogle Scholar
  73. Samaratunga H, Earle J, O’Loughlin B (1996) Nodular fasciitis and related pseudosarcomatous lesions of soft tissue. Aust N Z J Surg 66: 22–25PubMedCrossRefGoogle Scholar
  74. Enzinger FM, Weiss S (eds) (1994) Benign soft tissue tumors of uncertain type. In: Soft tissue tumors, 3rd edn. Mosby, St. Louis, pp 1053–1054Google Scholar
  75. Hernandez-Lugo AM, Domínguez-Cherit J, Vega-Memije ME (1999) Digital mucoid cyst: The ganglion type. Int J Dermatol 38: 531–538Google Scholar
  76. Enzinger FM, Weiss S (eds) (1994) Benign soft tissue tumors of uncertain type. In: Soft tissue tumors, 3rd edn. Mosby, St. Louis, pp 1051–1052Google Scholar
  77. Wilk M, Schmoeckel C (1994) Cutaneous focal mucinosis–a histopathological and immunohistochemical analysis of n cases. J Cutan Pathol 21: 446–452PubMedCrossRefGoogle Scholar
  78. Calonje E, Guerin D, McCormick D, Fletcher CDM (1999) Superficial angiomyxoma: Clinicopathological analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence Am J Surg Pathol 23: 910–917Google Scholar
  79. Carney JA, Headington JT, Daniel Su WP (1986) Cutaneous myxomas. Arch Dermatol 122: 790–798PubMedCrossRefGoogle Scholar
  80. Wilk M, Schmoeckel C, Kaiser HW, Hepple R Kreysel HW (1995) Cutaneous angiomyxoma: A benign neoplasm distinct from cutaneous focal mucinosis. J Am Acad Dermatol 33: 352–355Google Scholar
  81. Cooper PH (1992) Fibrous proliferations of infancy and childhood. J Cutan Pathol 19: 257–67PubMedCrossRefGoogle Scholar
  82. Gabbiani G, Majno G (1972) Dupuytren’s contracture: Fibroblast contraction? Am J Pathol 66: 131–146PubMedGoogle Scholar
  83. Häyry P, Reitamo JJ, Tötterman S, Hopfner-Hallikainen D, Sivula A (1982) The desmoid tumor. II. Am J Clin Pathol 77: 674–680Google Scholar
  84. Hügel H (1991) Die plaqueförmige dermale Fibromatose. Hautarzt 42: 223–226PubMedGoogle Scholar
  85. Hügel H, Allen PW (1995) Fibromatosen und andere fibroblastisch/myofibroblastisch differenzierte Bindegewebstumoren aus der Sicht des Dermatologen. Z Hautkr 70: 717–724Google Scholar
  86. Jennins TA, Duray PH, Collins FS, Sabetta J, Enzinger FM (1984) Infantile myofibromatosis. Evidence for an autosomal-dominant disorder. Am J Surg Pathol 18: 529–538Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • H. Audring
  • W. Sterry

There are no affiliations available

Personalised recommendations